These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10397695)

  • 1. Large amounts of vascular endothelial growth factor at the site of hemostatic plug formation in vivo.
    Weltermann A; Wolzt M; Petersmann K; Czerni C; Graselli U; Lechner K; Kyrle PA
    Arterioscler Thromb Vasc Biol; 1999 Jul; 19(7):1757-60. PubMed ID: 10397695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of recombinant hirudin (r-hirudin, HBW 023) on coagulation and platelet activation in vivo. Comparison with unfractionated heparin and a low-molecular-weight heparin preparation (fragmin).
    Eichinger S; Wolzt M; Schneider B; Nieszpaur-Los M; Heinrichs H; Lechner K; Eichler HG; Kyrle PA
    Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):886-92. PubMed ID: 7600120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ximelagatran, an oral direct thrombin inhibitor, r-hirudin and enoxaparin on thrombin generation and platelet activation in healthy male subjects.
    Sarich TC; Wolzt M; Eriksson UG; Mattsson C; Schmidt A; Elg S; Andersson M; Wollbratt M; Fager G; Gustafsson D
    J Am Coll Cardiol; 2003 Feb; 41(4):557-64. PubMed ID: 12598065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked increase in vascular endothelial growth factor concentrations during Escherichia coli endotoxin-induced acute inflammation in humans.
    Mittermayer F; Pleiner J; Schaller G; Weltermann A; Kapiotis S; Jilma B; Wolzt M
    Eur J Clin Invest; 2003 Sep; 33(9):758-61. PubMed ID: 12925034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor production by fibroblasts in response to factor VIIa binding to tissue factor involves thrombin and factor Xa.
    Ollivier V; Chabbat J; Herbert JM; Hakim J; de Prost D
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1374-81. PubMed ID: 10807756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct effects of recombinant desulfatohirudin (Revasc) and heparin on plasma levels of fibrinopeptide A and prothrombin fragment F1.2 in unstable angina. A multicenter trial.
    Rao AK; Sun L; Chesebro JH; Fuster V; Harrington RA; Schwartz D; Gallo P; Matos D; Topol EJ
    Circulation; 1996 Nov; 94(10):2389-95. PubMed ID: 8921778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the antithrombotic effect of PEG-hirudin and heparin in a human ex vivo model of arterial thrombosis.
    Bossavy JP; Sakariassen KS; Rübsamen K; Thalamas C; Boneu B; Cadroy Y
    Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1348-53. PubMed ID: 10323789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease.
    Webb NJ; Bottomley MJ; Watson CJ; Brenchley PE
    Clin Sci (Lond); 1998 Apr; 94(4):395-404. PubMed ID: 9640345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology.
    Banks RE; Forbes MA; Kinsey SE; Stanley A; Ingham E; Walters C; Selby PJ
    Br J Cancer; 1998 Mar; 77(6):956-64. PubMed ID: 9528841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro studies on thrombin generation in citrated, r-hirudinized and heparinized whole blood.
    Kaiser B; Fareed J; Walenga JM; Hoppensteadt D; Markwardt F
    Thromb Res; 1991 Dec; 64(5):589-96. PubMed ID: 1808763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of thrombin in the neo-vascularization of malignant gliomas: an intrinsic modulator for the up-regulation of vascular endothelial growth factor.
    Yamahata H; Takeshima H; Kuratsu J; Sarker KP; Tanioka K; Wakimaru N; Nakata M; Kitajima I; Maruyama I
    Int J Oncol; 2002 May; 20(5):921-8. PubMed ID: 11956584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor and basic fibroblast growth factor are found in resolving venous thrombi.
    Waltham M; Burnand KG; Collins M; Smith A
    J Vasc Surg; 2000 Nov; 32(5):988-96. PubMed ID: 11054231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets.
    Werther K; Christensen IJ; Nielsen HJ
    Scand J Clin Lab Invest; 2002; 62(5):343-50. PubMed ID: 12387579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactivity of the vascular endothelial growth factor trapped in fibrin clots: production of IL-6 and IL-8 in monocytes by fibrin clots.
    Tezono K; Sarker KP; Kikuchi H; Nasu M; Kitajima I; Maruyama I
    Haemostasis; 2001; 31(2):71-9. PubMed ID: 11684862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
    Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor.
    Salven P; Orpana A; Joensuu H
    Clin Cancer Res; 1999 Mar; 5(3):487-91. PubMed ID: 10100697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemiluminescence immunoassay for vascular endothelial growth factor (vascular permeability factor) in tumor-tissue homogenates.
    Schlaeppi JM; Eppenberger U; Martiny-Baron G; Küng W
    Clin Chem; 1996 Nov; 42(11):1777-84. PubMed ID: 8906076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma.
    Gasparini G; Toi M; Gion M; Verderio P; Dittadi R; Hanatani M; Matsubara I; Vinante O; Bonoldi E; Boracchi P; Gatti C; Suzuki H; Tominaga T
    J Natl Cancer Inst; 1997 Jan; 89(2):139-47. PubMed ID: 8998183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro release of vascular endothelial growth factor during platelet aggregation.
    Maloney JP; Silliman CC; Ambruso DR; Wang J; Tuder RM; Voelkel NF
    Am J Physiol; 1998 Sep; 275(3):H1054-61. PubMed ID: 9724313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of recombinant hirudin on tissue-factor-induced activation of coagulation in rabbits.
    Kouz J; Czech J; Nicolay U; Dickneite G
    Haemostasis; 1996; 26(4):179-86. PubMed ID: 8872128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.